Avenues to Non-Canonical T Cell Antigen Discovery in Cancer

Time: 12:00 pm
day: Focus Day


• Developing and validating new methods to simultaneously assay multiple
microbial antibodies in plasma
trials of real subjects
• Discussing the importance of plasma monitoring and how this proves to be a
useful tool for clinical decision making
• Evaluating the time and cost benefits of using new techniques compared to
ELISA methods
• Offering simultaneous quantification of several immune checkpoint inhibitors
likely to be associated in patients